Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated bianually. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News and Insights

Showing items 1 to3 of 6

Categories
Tags
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take: J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates
Insight
Our Take Newsletter
March 1, 2021

Our Take: J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates

Learn More
March 1, 2021
covid-19
covid
case
Our Take: Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication
Insight
Our Take Newsletter
March 8, 2021

Our Take: Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication

Learn More
March 8, 2021
vaccine
covid
covid-19
covid vaccine
Our Take: Merck, Ridgeback report early data indicating molnupiravir’s promise as potential COVID-19 treatment
Insight
Our Take Newsletter
March 15, 2021

Our Take: Merck, Ridgeback report early data indicating molnupiravir’s promise as potential COVID-19 treatment

Learn More
March 15, 2021
data
data visualization
health
2021
Biden
Our Take: Amazon Care takes a potentially giant step forward
Insight
Our Take Newsletter
March 22, 2021

Our Take: Amazon Care takes a potentially giant step forward

Learn More
March 22, 2021
amarin corp
amazon care
amazon
Amazon pharmacy
2021
Our Take: Increasing challenges plague hospitals one year into COVID-19, OIG report indicates
Insight
Our Take Newsletter
March 29, 2021

Our Take: Increasing challenges plague hospitals one year into COVID-19, OIG report indicates

Learn More
March 29, 2021
covid-19
covid
hospital
chance
2021
Our Take: Roundup of the latest COVID-19 vaccine news
Insight
Our Take Newsletter
April 5, 2021

Our Take: Roundup of the latest COVID-19 vaccine news

Learn More
April 5, 2021
covid cases
covid-19
covid
covid vaccine
2021
Our Take: Charity care spending at nonprofit hospitals falls short in new study
Insight
Our Take Newsletter
April 12, 2021

Our Take: Charity care spending at nonprofit hospitals falls short in new study

Learn More
April 12, 2021
healthcare
homecare
hospital
care
2021
Our Take: States pause use of J&J vaccine while FDA, CDC assess potential risk of rare blood clots
Insight
Our Take Newsletter
April 19, 2021

Our Take: States pause use of J&J vaccine while FDA, CDC assess potential risk of rare blood clots

Learn More
April 19, 2021
united states
fda
cdc
CDC foundation
2021
Our Take: Insurers continue to reap profits, announce acquisitions in Q1
Insight
Our Take Newsletter
April 26, 2021

Our Take: Insurers continue to reap profits, announce acquisitions in Q1

Learn More
April 26, 2021
insurers
insurance
prescription drugs
2021
amazon
Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion
Insight
Our Take Newsletter
May 3, 2021

Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion

Learn More
May 3, 2021
Humana
humira
best buy
home
2021
Our Take: Walmart to acquire on-demand telehealth provider MeMD
Insight
Our Take Newsletter
May 10, 2021

Our Take: Walmart to acquire on-demand telehealth provider MeMD

Learn More
May 10, 2021
walmart
telehealth
memorial hermann health system
health
2021
Our Take: BD to spin off diabetes business into new publicly traded company
Insight
Our Take Newsletter
May 17, 2021

Our Take: BD to spin off diabetes business into new publicly traded company

Learn More
May 17, 2021
harvard business school
business
common
virtual health
2021
Stay Aware. Stay Informed.

Want to strengthen your account planning?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.